I think H would rather see them rush through a phase II and...

I think H would rather see them rush through a phase II and screw it up... but that is not happening here, there is too much going on and it all has to be signed off ethically with a comprehensive audit trail and data integrity that fulfils the requirements of big pharma, who may come knocking at any stage.

LuPIN is a new story for us, that was investigator initiated and not even rating a mention early days. Its a commercially active space with a fair bit still to play out. Happy waiting and holding for developments down the line. We are not privvy to the discussions and opportunities in front of Graham and co.